Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 113 citing articles:

Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy
Nilanjan Adhikari, Tarun Jha, Balaram Ghosh
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 13, pp. 8827-8869
Closed Access | Times Cited: 44
HIPK2 phosphorylates HDAC3 for NF-κB acetylation to ameliorate colitis-associated colorectal carcinoma and sepsis
Fang Zhang, Linlin Qi, Qiuyun Feng, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 28
Open Access | Times Cited: 43
Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy
Su Zhang, Yang Meng, Lian Zhou, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 35
The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3
Lulu Ni, Lixin Wang, Chao Yao, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 61
The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors
Fangyuan Cao, Martijn R. H. Zwinderman, Frank J. Dekker
Molecules (2018) Vol. 23, Iss. 3, pp. 551-551
Open Access | Times Cited: 55
Combination Therapies Targeting HDAC and IKK in Solid Tumors
Ivana Vancurova, Mohammad M. Uddin, Yue Zou, et al.
Trends in Pharmacological Sciences (2017) Vol. 39, Iss. 3, pp. 295-306
Open Access | Times Cited: 51
The Therapeutic Effects of Treadmill Exercise on Osteoarthritis in Rats by Inhibiting the HDAC3/NF-KappaB Pathway in vivo and in vitro
He Zhang, Lü Ji, Yue Yang, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 47
Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach
Yudibeth Sixto‐López, Martiniano Bello, José Correa‐Basurto
Journal of Computer-Aided Molecular Design (2020) Vol. 34, Iss. 8, pp. 857-878
Closed Access | Times Cited: 43
The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury
Ning Li, Rui Xiong, Wang Bo, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 8
Open Access | Times Cited: 39
Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity
María Laura Sáiz, Marta L. DeDiego, Darío López-García, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Determination of Slow-Binding HDAC Inhibitor Potency and Subclass Selectivity
Carlos Moreno–Yruela, Christian A. Olsen
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 5, pp. 779-785
Open Access | Times Cited: 23
Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology
Rahul Patil, McKenzie E. Maloney, Rudolf Lucas, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 140-140
Open Access | Times Cited: 5
Paeonol Suppresses Neuroinflammatory Responses in LPS-Activated Microglia Cells
He Li, Xiaoyun Tong, Jing Zeng, et al.
Inflammation (2016) Vol. 39, Iss. 6, pp. 1904-1917
Closed Access | Times Cited: 45
Manipulating macrophage polarization and function using classical HDAC inhibitors: Implications for autoimmunity and inflammation
Asadollah Mohammadi, A Amin Sharifi, Reza Pourpaknia, et al.
Critical Reviews in Oncology/Hematology (2018) Vol. 128, pp. 1-18
Closed Access | Times Cited: 45
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
Vanessa Neuhaus, Olga Danov, Sebastian Konzok, et al.
Journal of Visualized Experiments (2018), Iss. 135
Open Access | Times Cited: 42
Targeting HDAC Complexes in Asthma and COPD
Martijn R. H. Zwinderman, Sander de Weerd, Frank J. Dekker
Epigenomes (2019) Vol. 3, Iss. 3, pp. 19-19
Open Access | Times Cited: 42
Small molecules as tools to study the chemical epigenetics of lysine acetylation
Matthias Schiedel, Stuart J. Conway
Current Opinion in Chemical Biology (2018) Vol. 45, pp. 166-178
Closed Access | Times Cited: 39
HDAC3 Inhibitor RGFP966 Ameliorated Neuroinflammation in the Cuprizone-Induced Demyelinating Mouse Model and LPS-Stimulated BV2 Cells by Downregulating the P2X7R/STAT3/NF-κB65/NLRP3 Activation
Wei Sun, Ning Zhang, Bingyi Liu, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 17, pp. 2579-2598
Closed Access | Times Cited: 22
Butyrate Prevents Induction of CXCL10 and Non-Canonical IRF9 Expression by Activated Human Intestinal Epithelial Cells via HDAC Inhibition
Sandra G. P. J. Korsten, Laura Peracic, Luka M. B. van Groeningen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3980-3980
Open Access | Times Cited: 20
Electrochemical Synthesis of New Isoxazoles and Triazoles Tethered with Thiouracil Base as Inhibitors of Histone Deacetylases in Human Breast Cancer Cells
Divakar Vishwanath, Xi Zhang, Akshay Ravish, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5254-5254
Open Access | Times Cited: 12
A TLR4/TRAF6-dependent signaling pathway mediates NCoR coactivator complex formation for inflammatory gene activation
Yohei Abe, Eric Kofman, Zhengyu Ouyang, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 2
Open Access | Times Cited: 4
The role of HDAC3 in inflammation: mechanisms and therapeutic implications
Noah Watson, Sivaraman Kuppuswamy, William Luke Ledford, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Overview of Class I HDAC Modulators: Inhibitors and Degraders
Ziqian Huang, Limei Zeng, Binbin Cheng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116696-116696
Closed Access | Times Cited: 4
Histone Deacetylation in Alzheimer’s Diseases (AD); Hope or Hype
Nabaa Hisham Ateya, Sarah F. Al-Taie, Saade Abdalkareem Jasim, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
HDAC inhibitors and IBD: Charting new approaches in disease management
Xueting Du, Weilai Yu, Fangyu Chen, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114193-114193
Closed Access

Scroll to top